• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌中的人乳头瘤病毒DNA——与临床数据的相关性及对预后的影响

Human papillomavirus DNA in cervical carcinoma--correlation with clinical data and influence on prognosis.

作者信息

Ikenberg H, Sauerbrei W, Schottmüller U, Spitz C, Pfleiderer A

机构信息

Department of Obstetrics and Gynecology, University of Freiburg, Germany.

出版信息

Int J Cancer. 1994 Nov 1;59(3):322-6. doi: 10.1002/ijc.2910590306.

DOI:10.1002/ijc.2910590306
PMID:7927936
Abstract

Human papillomavirus (HPV) is a main factor in cervical carcinogenesis. However, data on the correlation of HPV with clinical features and the prognosis of cervical carcinoma remain controversial. The HPV status (positivity, type, copy number) in unfixed tissue specimens of 205 primary invasive cervical carcinomas was determined by Southern blot hybridization. A correlation with comprehensive clinical and histopathologic data and long-time survival was evaluated. HPV DNA was detected in 73% of the cases; 83% of the HPV-positive tumors contained HPV 16. HPV 16 was predominant among squamous-cell carcinomas (SCC) (p = 0.05). HPV 16 copy number was higher in keratinizing tumors (p < 0.05), and elevated levels of the SCC antigen were more common in patients positive for HPV 16 (p < 0.03). No association was found between the HPV status and 8 other clinical and histopathologic variables. Multivariate analysis after a median follow-up of 73 months demonstrated longer survival for patients with lower clinical stage (p = 0.001) and keratinizing SCC (p = 0.005). Women with HPV-negative tumors had a higher risk of death (RR 1.51; p = 0.07). HPV analysis does not clearly define biologically distinct sub-sets of cervical carcinoma. This underlines the importance of additional factors in cervical carcinogenesis.

摘要

人乳头瘤病毒(HPV)是宫颈癌发生的主要因素。然而,关于HPV与宫颈癌临床特征及预后相关性的数据仍存在争议。通过Southern印迹杂交法测定了205例原发性浸润性宫颈癌未固定组织标本中的HPV状态(阳性、类型、拷贝数)。评估了其与综合临床和组织病理学数据及长期生存的相关性。73%的病例检测到HPV DNA;83%的HPV阳性肿瘤含有HPV 16。HPV 16在鳞状细胞癌(SCC)中占主导地位(p = 0.05)。HPV 16拷贝数在角化性肿瘤中更高(p < 0.05),SCC抗原水平升高在HPV 16阳性患者中更常见(p < 0.03)。未发现HPV状态与其他8个临床和组织病理学变量之间存在关联。中位随访73个月后的多变量分析表明,临床分期较低(p = 0.001)和角化性SCC(p = 0.005)的患者生存期更长。HPV阴性肿瘤的女性死亡风险更高(相对风险1.51;p = 0.07)。HPV分析不能明确界定宫颈癌在生物学上不同的亚组。这突出了宫颈癌发生中其他因素的重要性。

相似文献

1
Human papillomavirus DNA in cervical carcinoma--correlation with clinical data and influence on prognosis.宫颈癌中的人乳头瘤病毒DNA——与临床数据的相关性及对预后的影响
Int J Cancer. 1994 Nov 1;59(3):322-6. doi: 10.1002/ijc.2910590306.
2
Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.原发性宫颈癌及无癌盆腔淋巴结中的人乳头瘤病毒(HPV)DNA——与临床病理参数的相关性及预后意义
Zentralbl Gynakol. 2001 Feb;123(2):91-101. doi: 10.1055/s-2001-12411.
3
The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.宫颈癌中人乳头瘤病毒DNA的存在:与临床病理参数的相关性及预后意义:美因茨大学妇产科十年经验
Int J Gynecol Cancer. 2001 Jan-Feb;11(1):39-48. doi: 10.1046/j.1525-1438.2001.011001039.x.
4
Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.使用原位聚合酶链反应检测人乳头瘤病毒在宫颈腺癌和腺鳞癌中的定位:这些癌症中人乳头瘤病毒检测的文献综述
Pathol Int. 2006 Jun;56(6):301-8. doi: 10.1111/j.1440-1827.2006.01964.x.
5
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.人乳头瘤病毒基因型在宫颈癌中的分布:一项回顾性、全球性的横断面研究。
Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.
6
Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa, Japan.日本冲绳地区女性宫颈癌原发灶及转移灶中人乳头瘤病毒DNA的检测
Am J Clin Oncol. 2001 Apr;24(2):160-6. doi: 10.1097/00000421-200104000-00013.
7
HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.HPV 阴性宫颈癌:一种预后较差的宫颈癌特殊类型。
BJOG. 2015 Jan;122(1):119-27. doi: 10.1111/1471-0528.13071. Epub 2014 Sep 17.
8
Correlation of human papillomavirus 16 and 18 with cervical neoplasia in histological typing and clinical stage in Taiwan: an in-situ polymerase chain reaction approach.台湾地区人乳头瘤病毒16型和18型与宫颈肿瘤组织学类型及临床分期的相关性:原位聚合酶链反应研究
J Surg Oncol. 2001 Oct;78(2):101-9. doi: 10.1002/jso.1128.
9
Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha.
Clin Biochem. 2001 Sep;34(6):491-8. doi: 10.1016/s0009-9120(01)00243-0.
10
Cytomegalovirus and cervical cancer: failure to detect a direct association or an interaction with human papillomaviruses.巨细胞病毒与宫颈癌:未检测到其与人类乳头瘤病毒的直接关联或相互作用。
Gynecol Oncol. 1994 Jul;54(1):40-6. doi: 10.1006/gyno.1994.1163.

引用本文的文献

1
Associations between genetic HPV 16 diversity and cervical cancer prognosis.人乳头瘤病毒16型(HPV 16)基因多样性与宫颈癌预后之间的关联。
PLoS One. 2025 Jun 25;20(6):e0308895. doi: 10.1371/journal.pone.0308895. eCollection 2025.
2
Multicentre, randomised controlled trial of adjuvant chemotherapy in cervical cancer with residual human papilloma virus DNA following primary radiotherapy or chemoradiotherapy: a study protocol.多中心、随机对照试验:辅助化疗在原发性放疗或放化疗后 HPV DNA 残留的宫颈癌中的应用:研究方案。
BMJ Open. 2019 Oct 7;9(10):e028171. doi: 10.1136/bmjopen-2018-028171.
3
Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
利用治疗前淋巴结 SUVmax 和 HPV 状态增强宫颈癌预后预测。
Cancer Imaging. 2019 Jun 24;19(1):43. doi: 10.1186/s40644-019-0226-4.
4
Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.治疗前宫颈癌中HPV DNA状态的预后价值:一项系统评价和荟萃分析。
Oncotarget. 2017 Jun 16;8(39):66352-66359. doi: 10.18632/oncotarget.18558. eCollection 2017 Sep 12.
5
Tumor size and lymph node status determined by imaging are reliable factors for predicting advanced cervical cancer prognosis.通过影像学确定的肿瘤大小和淋巴结状态是预测晚期宫颈癌预后的可靠因素。
Oncol Lett. 2015 May;9(5):2218-2224. doi: 10.3892/ol.2015.3015. Epub 2015 Mar 5.
6
Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment.人乳头瘤病毒类型和种类在接受初始治疗的宫颈癌患者中的预后意义
PLoS One. 2015 Apr 9;10(4):e0122557. doi: 10.1371/journal.pone.0122557. eCollection 2015.
7
Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia.马来西亚口腔鳞状细胞癌与高危型人乳头瘤病毒(HPV)显著相关,但与 p53 多态性无关。
J Cancer Res Clin Oncol. 2011 Feb;137(2):311-20. doi: 10.1007/s00432-010-0886-8. Epub 2010 Apr 24.
8
Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue.实时PCR信号放大原位杂交与传统PCR检测和定量存档宫颈癌组织中人乳头瘤病毒的比较
J Clin Microbiol. 2004 Aug;42(8):3758-65. doi: 10.1128/JCM.42.8.3758-3765.2004.
9
Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.用于高度敏感地广谱检测肛门生殖器人乳头瘤病毒的新型短片段聚合酶链反应检测法。
Am J Pathol. 1998 Dec;153(6):1731-9. doi: 10.1016/S0002-9440(10)65688-X.
10
Use of multiple PCR primer sets for optimal detection of human papillomavirus.使用多种聚合酶链反应引物组以实现人乳头瘤病毒的最佳检测。
J Clin Microbiol. 1996 Sep;34(9):2095-100. doi: 10.1128/jcm.34.9.2095-2100.1996.